Close

Analyst Ratings for Corcept Therapeutics (CORT) [Buys]

CORT Rating Summary

CORT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CORT
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $35.60 (+46.4%) * Over Last 12-Mos
Rating Score: 4.1 / 10   Percentile Rank: 41%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/4/2023 Piper Sandler
» Updated 10/18/2023
David Amsellem New Coverage Overweight
(N/A)
35.00
(31.00)
21.66
(24.31)
12.23% Details
6/27/2022 Canaccord Genuity
» Updated 12/13/2023
Edward Nash New Coverage Buy
(N/A)
38.00
(37.00)
23.80
(24.31)
2.14% Details
Like CORT Ratings? Also take a look at TEVA

CORT Ratings News